Doxycycline vs. levofloxacin in the treatment of community-acquired pneumonia.

Mokabberi, R; Haftbaradaran, A; Ravakhah, K

Mokabberi, R; Haftbaradaran, A; Ravakhah, K.

Affiliation

Mokabberi R; Department of Medicine, Huron Hospital, Cleveland Clinic Hospital, Cleveland, OH 44112, USA.

J Clin Pharm Ther ; 35(2): 195-200, 2010 Apr.

Article in En | MEDLINE | ID: mdl-20456738

Subject(s)

Anti-Bacterial Agents/therapeutic use; Doxycycline/therapeutic use; Levofloxacin; Ofloxacin/therapeutic use; Pneumonia, Bacterial/drug therapy; Adult; Aged; Anti-Bacterial Agents/economics; Community-Acquired Infections/drug therapy; Double-Blind Method; Doxycycline/economics; Drug Costs; Female; Follow-Up Studies; Humans; Length of Stay; Male; Middle Aged; Ofloxacin/economics; Prospective Studies; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ofloxacin / Doxycycline / Pneumonia, Bacterial / Levofloxacin / Anti-Bacterial Agents Type of study: Clinical_trials / Guideline / Observational_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Clin Pharm Ther Journal subject: FARMACIA / TERAPEUTICA Year: 2010 Document type: Article Affiliation country: United States Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google